These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 35436987)

  • 1. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer.
    He T; Xia H; Chen B; Duan Z; Huang C
    Crit Rev Immunol; 2023; 43(3):43-53. PubMed ID: 37824376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent manner.
    Huang C; Duan Z; Chen B; Xia H; Wang G
    Adv Clin Exp Med; 2024 Aug; ():. PubMed ID: 39136331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway.
    Li C; Xie P; Lv K; Yang Q; Mou Y
    Endocr Metab Immune Disord Drug Targets; 2024 Jul; ():. PubMed ID: 39021178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
    He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
    Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
    Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
    Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
    Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
    Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 regulates thyroid cancer differentiation and chemosensitivity by modulating PAX8.
    Kang N; Zhao Z; Wang Z; Ning J; Wang H; Zhang W; Ruan X; Gao M; Zheng X
    Int J Biol Sci; 2024; 20(9):3426-3441. PubMed ID: 38993572
    [No Abstract]   [Full Text] [Related]  

  • 12. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 suppresses invasion of lung cancer via SH3BP5 m6A modification.
    Zhang B; Qian R; Li X
    Arch Biochem Biophys; 2024 Feb; 752():109876. PubMed ID: 38141906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.
    Zhang Z; Fu J; Zhang Y; Qin X; Wang Y; Xing C
    BMC Gastroenterol; 2023 Jun; 23(1):217. PubMed ID: 37344779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
    Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S
    Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 restrains papillary thyroid cancer progression via m
    He J; Zhou M; Yin J; Wan J; Chu J; Jia J; Sheng J; Wang C; Yin H; He F
    Mol Ther; 2021 May; 29(5):1821-1837. PubMed ID: 33484966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.
    Xie R; Chen W; Lv Y; Xu D; Huang D; Zhou T; Zhang S; Xiong C; Yu J
    J Formos Med Assoc; 2023 Aug; 122(8):738-746. PubMed ID: 36739231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J; Peng F; Zhao J; Gong X
    Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.